Jing Xia

471 total citations · 1 hit paper
20 papers, 302 citations indexed

About

Jing Xia is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Jing Xia has authored 20 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Nephrology and 3 papers in Genetics. Recurrent topics in Jing Xia's work include Chronic Lymphocytic Leukemia Research (3 papers), Renal Diseases and Glomerulopathies (3 papers) and Platelet Disorders and Treatments (2 papers). Jing Xia is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Renal Diseases and Glomerulopathies (3 papers) and Platelet Disorders and Treatments (2 papers). Jing Xia collaborates with scholars based in China, United States and Australia. Jing Xia's co-authors include Xinguang Liu, Yousin Suh, Miook Cho, Jie Cheng, Xing‐dong Xiong, Yusuke Suzuki, Tak Mao Chan, Jill Yarbrough, Brian J.G. Pereira and Jonathan Barratt and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Jing Xia

16 papers receiving 294 citations

Hit Papers

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nep... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Xia China 8 130 99 94 43 39 20 302
Jianliang Wu China 7 149 1.1× 94 0.9× 112 1.2× 75 1.7× 24 0.6× 17 393
Joe Matsuoka Japan 9 52 0.4× 39 0.4× 103 1.1× 37 0.9× 36 0.9× 17 306
Jia Xing China 8 192 1.5× 102 1.0× 45 0.5× 29 0.7× 17 0.4× 11 333
Jun Zou China 13 143 1.1× 32 0.3× 138 1.5× 42 1.0× 16 0.4× 27 400
Yaling Bai China 12 218 1.7× 150 1.5× 102 1.1× 27 0.6× 10 0.3× 50 428
Jingsong Shi China 10 150 1.2× 50 0.5× 177 1.9× 45 1.0× 8 0.2× 33 392
Kana Ide Japan 10 154 1.2× 57 0.6× 72 0.8× 41 1.0× 8 0.2× 14 298
Ruimin Hu China 10 124 1.0× 29 0.3× 173 1.8× 66 1.5× 24 0.6× 22 301
Qianqian Wang China 6 181 1.4× 68 0.7× 84 0.9× 26 0.6× 16 0.4× 9 370
Gaosi Xu China 8 177 1.4× 54 0.5× 73 0.8× 30 0.7× 8 0.2× 13 297

Countries citing papers authored by Jing Xia

Since Specialization
Citations

This map shows the geographic impact of Jing Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Xia more than expected).

Fields of papers citing papers by Jing Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Xia. The network helps show where Jing Xia may publish in the future.

Co-authorship network of co-authors of Jing Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Xia. A scholar is included among the top collaborators of Jing Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Xia. Jing Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Jing, Xiaolin Zhang, Ling Xu, et al.. (2025). Sodium butyrate attenuates oxidative stress, apoptosis, and excessive mitophagy in sodium fluoride-induced hepatotoxicity in rats. Ecotoxicology and Environmental Safety. 291. 117821–117821. 4 indexed citations
2.
Perkovic, Vlado, Jonathan Barratt, Richard Lafayette, et al.. (2025). Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial. Kidney International Reports. 10(12). 4207–4218.
3.
Cui, Xiaodong, Jing Xia, Chongzhi Bai, et al.. (2025). Glutaredoxin 1 enhances endothelial cell angiogenesis by reducing VEGFA S-glutathionylation and delays vascular endothelial cell senescence. Free Radical Biology and Medicine. 237. 515–529. 1 indexed citations
5.
Lafayette, Richard, Hernán Trimarchi, Jonathan Barratt, et al.. (2025). WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY. Kidney International Reports. 10(2). S158–S159. 2 indexed citations
6.
Xia, Jing, et al.. (2024). Promoting leisure functions through setting creative linguistic landscapes in recreational zones. PLoS ONE. 19(3). e0299775–e0299775. 2 indexed citations
7.
Xu, Ziyang, Jing Xia, & Xing‐dong Xiong. (2023). Emerging Role and Mechanism of the FTO Gene in Cardiovascular Diseases. Biomolecules. 13(5). 850–850. 22 indexed citations
8.
Chen, Min, Xiang Liu, Xiaoling Wei, et al.. (2023). Is the incident of once chronic obstructive pulmonary disease related admission a high risk for readmission in the future?. Journal of Thoracic Disease. 15(6). 3133–3142.
9.
Mathur, Mohit, Jonathan Barratt, Bobby Chacko, et al.. (2023). A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. New England Journal of Medicine. 390(1). 20–31. 100 indexed citations breakdown →
10.
Chen, Mianmian, Xian Zhang, Lifeng Yang, et al.. (2023). DegU-mediated suppression of carbohydrate uptake in Listeria monocytogenes increases adaptation to oxidative stress. Applied and Environmental Microbiology. 89(10).
11.
Huang, Qianwen, et al.. (2023). Friction-induced vibration of marine propeller shaft based on the LuGre friction model. Journal of Mechanical Science and Technology. 37(8). 3867–3876. 5 indexed citations
12.
Xie, Lijun, et al.. (2021). Plasma interleukin-21 levels and genetic variants are associated with susceptibility to rheumatoid arthritis. BMC Musculoskeletal Disorders. 22(1). 246–246. 7 indexed citations
14.
Xia, Jing, et al.. (2017). Features of continuous glycemic profile and glycemic variability in patients with obstructive sleep apnea syndrome. Diabetes Research and Clinical Practice. 134. 106–112. 10 indexed citations
15.
Yang, Lu, et al.. (2017). Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt/NOS/NF-κB signaling. Molecular Medicine Reports. 17(3). 4099–4105. 12 indexed citations
16.
Xia, Jing, et al.. (2017). Neuroprotective effect of tanshinone IIA weakens spastic cerebral palsy through inflammation, p38MAPK and VEGF in neonatal rats. Molecular Medicine Reports. 17(1). 2012–2018. 17 indexed citations
17.
Xia, Jing, et al.. (2015). Association of APOA5 T1131C polymorphism and risk of coronary artery disease.. PubMed. 8(6). 8986–94. 7 indexed citations
18.
Cho, Miook, et al.. (2014). A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 761. 15–20. 93 indexed citations
19.
Xiong, Xing‐dong, Xiping Luo, Xinguang Liu, et al.. (2012). The MBD4 Glu346Lys Polymorphism Is Associated With the Risk of Cervical Cancer in a Chinese Population. International Journal of Gynecological Cancer. 22(9). 1552–1556. 12 indexed citations
20.
Xia, Jing, et al.. (2011). [Clinical analysis in viral encephalitis patients accompanying generalized tonic clonic seizure].. PubMed. 25(3). 217–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026